Both in Biotechnology
Anavex Life Sciences vs Compass Therapeutics
Over the past year AVXL returned −77.3% and CMPX returned −70.3%; their daily moves had a correlation of 0.09.
AVXL −77.3% CMPX −70.3%Growth of $1, one year, split-adjusted
| Metric | AVXL | CMPX |
|---|---|---|
| Price | $2.02 | $1.04 |
| Market cap | $187.2M | $187.3M |
| Today | −14.41% | −5.45% |
| 1 month | −27.9% | −56.5% |
| 6 months | −34.2% | −80.3% |
| Year to date | −43.3% | −80.6% |
| 1 year | −76.6% | −72.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $118.3M | $179.9M |
| Dividend yield | — | — |
| Volatility (60d) | 73.8% | 94.6% |
| Short % of float | 16.0% | 36.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).